Jinan Hongyuan Chemical Co.,Ltd

Jinan Hongyuan Chemical Co.,Ltd

86-176-86865661

Jinan Hongyuan Chemical Co.,Ltd
Home> Industry Information

Industry Information

Update April 22, 2021
Top 10 "Medical Ecological Innovation Labs" in the world: Cardano, BJC Medical, Google...
From remote patient monitoring to translational science, emerging technologies are disrupting the medical industry. With the development of the medical industry, top medical companies and scientific...
Read more >
Update April 20, 2021
Baiji Shenzhou new production base approved for commercial production
Beijing, China and Cambridge, Massachusetts, USA April 8, 2021, Baiji Shenzhou (NASDAQ: bgne; SEHK: 06160) is a biotechnology company in the commercial stage, focusing on the development and...
Read more >
Update February 01, 2021
Two anti-PD-L1 McAbs are to be included in the breakthrough treatment
On January 28, 2021, CDE announced the list of two breakthrough treatment varieties to be included. Source: CDE website 1. Zhaoke anti-PD-L1 monoclonal antibody is to be included in breakthrough...
Read more >
Update February 01, 2021
In 2020, four car-t enterprises will apply for and be approved at the same time, and six enterprises will raise more than 3.2 billion yuan in total
A few days ago, according to the official website of the State Drug Administration (nmpa), the application for the listing of Fosun Kate car-t product akilunsai injection has entered the stage of...
Read more >
Update January 29, 2021
2020 inventory: Top 10 clinical trial failure cases! Roche is the most, AstraZeneca, Sanofi, GSK
It is a highly subjective task to list the most failed clinical trials in 2020, and the trials on the list need to have a significant impact on pharmaceutical companies and patients targeted by...
Read more >
Update January 29, 2021
2020 inventory: 150 billion US dollars antibody drug market competition intensifies, domestic innovative pharmaceutical enterprises rise rapidly, Hengrui, Junshi, Xinda
Antibody drugs only have a history of more than 30 years, and have entered the outbreak stage in the past five years. By the end of 2020, the US FDA has approved 99 Kinds of antibody drugs on the...
Read more >
Update January 26, 2021
100 billion US dollars diabetes drug market, dulaglutide compound growth rate of 124.2% in five years
Overview of diabetes Definition of diabetes Diabetes is caused by genetic and environmental factors, with abnormal glucose metabolism as the main performance of the disease. The absolute or relative...
Read more >
Update January 26, 2021
Domestic car-t therapy will be on the market soon! How much room for price reduction in cell therapy?
Cellular immunotherapy has experienced a long history of development, and ushered in a breakthrough in recent years. Up to now, there are 366 car-t products under research in the global market, and...
Read more >
Update January 23, 2021
Five important issues in the field of gene therapy in 2021
Three years ago, the U.S. FDA granted a landmark approval for luxturna to treat an inherited retinal disease (IRD) that can cause blindness. This is the first real gene therapy in the U.S. market,...
Read more >
Update January 23, 2021
"Biological missile" ADC drugs usher in the golden age, challenge the next 100 billion market!
In 2000, the first ADC drug appeared on the market, but it has been tepid. Until 2019, the FDA has approved three ADC drugs (poly ivy, padcev and enhertu), and ADC drugs known as "biological...
Read more >
Home> Industry Information
Related Products List

Home

Product

Whatsapp

About Us

Inquiry

We will contact you immediately

Fill in more information so that we can get in touch with you faster

Privacy statement: Your privacy is very important to Us. Our company promises not to disclose your personal information to any external company with out your explicit permission.

Send